實驗室自動化與篩選協(xié)會2015亞洲年會（SLAS2015）
時間：2015-04-09 08:00 至 2015-04-10 18:00
地點：上海
- 參會報名
- 會議通知
- 會議門票
- 會議日程
- 會議嘉賓
-
手機下單
首頁 > 商務(wù)會議 > 教育培訓(xùn)會議 > 實驗室自動化與篩選協(xié)會2015亞洲年會（SLAS2015） 更新時間：2015-02-04 15:46:13
|
實驗室自動化與篩選協(xié)會2015亞洲年會（SLAS2015） 已截止報名會議時間： 2015-04-09 08:00至 2015-04-10 18:00結(jié)束 會議地點： 上海 詳細(xì)地址會前通知 周邊酒店預(yù)訂 主辦單位： |
收藏3人
換一換
會議通知
實驗室自動化與篩選協(xié)會2015亞洲年會將于2015年4月9日-10日在上海浦東康橋加入酒店召開。作為推動科學(xué)與技術(shù)相結(jié)合的平臺，SLAS聚集了來自全球的18000名生命科學(xué)領(lǐng)域的研發(fā)精英，包括科學(xué)家、技術(shù)提供商、研究人員、學(xué)術(shù)人員和學(xué)生、工程師、信息學(xué)專家以及商業(yè)領(lǐng)袖。SLAS組織并提供全年的教育和交流活動，致力于為全球科學(xué)和技術(shù)領(lǐng)域的專業(yè)人員建立聯(lián)系并達(dá)成合作創(chuàng)新。?
第四屆SLAS亞洲會展將于2015年4月9日-10日在上海世紀(jì)皇冠假日酒店舉行。本屆大會主題為“Come Transform Research”。中科院院士高福、饒子和、王曉東等多位學(xué)術(shù)界知名科學(xué)家攜手跨國藥企、CRO和技術(shù)服務(wù)企業(yè)的科研人員及高管，擔(dān)任本屆大會演講嘉賓。他們將從小分子、天然產(chǎn)物、大分子等不同角度出發(fā)，和參會者共同探討新藥發(fā)現(xiàn)的最新研究成果及技術(shù)創(chuàng)新。內(nèi)容包含靶標(biāo)確認(rèn)、高通量篩選、轉(zhuǎn)化醫(yī)學(xué)、抗體研究等熱門主題。多樣化的研究領(lǐng)域和方向?qū)⑹沟帽敬未髸始姵省?/p>
本屆大會不僅從多元化角度為參會者們呈現(xiàn)新藥發(fā)現(xiàn)領(lǐng)域的前沿科學(xué)性內(nèi)容。同時，還將以實例跟大家分享學(xué)術(shù)產(chǎn)業(yè)界的合作如何促進科學(xué)研究成果的轉(zhuǎn)化。在為期兩天的同期展會中，三十多家跨國公司將展示最新實驗室自動化儀器和相關(guān)技術(shù)。本屆大會也是SLAS與生物醫(yī)藥創(chuàng)新社的首次合作，其2015年會將于4月10日同期召開。
會議亮點
——Frontier scientific programs present different approaches to drug discovery from small molecules to biologics
——Emphasize the connection between academia and Industries to advance the commercialization of scientific findings
——Over 30 multinational companies showcase the latest laboratory technologies
——Special Session: Biologics Innovation Group 2015 Annual Conference
時間地點
會議時間：2015年4月9-10日
會議地點：上海
查看更多
會議門票
參會費用：1月28日前，650元/人；1月28日之后，800元/人；標(biāo)準(zhǔn)價格 1000元/人。
?
查看更多
會議日程
（最終日程以會議現(xiàn)場為準(zhǔn)）
| 4月9日 星期四 | |
| 08:4509:00 | ?SLAS Opening Remarks |
| 09:00-09:45 | ?Keynote 1: Going Fishing for Better Medicines ?Karl Barry Sharpless, Nobel Prize Laureate, W. M. Keck Professor of Chemistry, The Scripps Research Institute, California |
| 09:45-12:45 | ?Session 1: Leading Science for Small Molecules Drug Discovery ?Co-chairs:? ?Jonathan Connick, Executive Director, Head External in Vitro Pharmacology. Site Head, EDDS and PCD China, Merck & Co Inc., Member of SLAS Asia Council ?Bin Li, R&D Director, AbbVie China R&D Center, Secretary of SLAS Asia Council |
| 09:45-10:15 | ?Topic tbc ?Xin Xie, SIMM? |
| 10:15-10:45 | ?Phenotypic Drug Discovery and Target Deconvolution ?Jing Li, Director of Pharmacology; Department of Screening and Protein Science; Merck Research Laboratories (MRL) |
| 10:45-11:15 | ?Break in Exhibit Hall |
| 11:15-11:45 | ?Discovery of HIV Integrase Inhibitors ?John Wai, Vice President of Medicinal Chemistry, WuXi AppTec (Shanghai) |
| 11:45-12:45 | ?Panel Discussion：Leveraging Technology and Tools to Enable Drug Discovery ?Moderator: Jonathan Connick, Executive Director, Head External in Vitro ?Pharmacology. Site Head, EDDS and PCD China, Merck & Co., Inc., Member of SLAS Asia Council ?Panelist:? ?Pharma – Jing Li, Director of Pharmacology; Department of Screening and Protein Science; Merck Research Laboratories (MRL) ?CRO - Xuehai Tan, CEO & President, HD Biosciences Co., Ltd. ?Technology Provider - Joe Gu, LST APAC VP GM, Perkin Elmer ?Academia – Jian Li / Xin Xie - tbc |
| 12:45_14:30 | ?Lunch in Exhibit Hall |
| 12:45-14:30 | ?Posters |
| 13:30-14:15 | ?Exhibitor Tutorial 1?? ?Exhibitor Tutorial 2 |
| 14:30-17:00 | ?Session 2: Natural Product Drug Discovery & Synthetic Biology ?Co-chairs: ?Bing Xie, Managing Director, Asia Pacific for Cisbio Bioassays, Member of SLAS Asia Council ?Mike Zhang, Associate Sales Director, Research, BD Biosciences, Member of SLAS Asia Council |
| 14:30-15:00 | ?Discovery of NITD609 as Antimalarial: From Natural Product-like Lead to Clinical Candidate ?Bin Zou, Senior Medicinal Chemist, Novartis Institute for Tropical Diseases (Singapore) |
| 15:00-15:30 | ?HTS Hits - Which Should You Discard, and Why? ?Jonathan Baell, Research Professor, Medicinal Chemistry, Monash Institute of Pharmaceutical Science |
| 15:30-16:00 | ?Break in Exhibit Hall |
| 16:00-16:30 |
Anti-infective and Anti-tumor Natural Products Discovery and Biosynthesis from Marine Actinomycetes |
| 16:30-17:00 | ?Anti-infectious Natural Products from Marine-derived Microbes ?Xueting Liu, Associate Professor , CAS Key Laboratory of Pathogenic Microbiology & Immunology |
| 17:00-17:30 | ?Topic tbc ?Hakim Djaballah - tbc |
| 17:30-19:00 | ?Reception |
| 4月10日 星期五 ?Biologics Innovation Group 2015 Annual Conference | |
| 08:45-09:00 | ?Welcome Speech- Biologics Enabling Working Group Annual Conference? ?Bill Jiang, ?Director, Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University |
| 09:00-09:45 | ?Keynote 2 : Vaccine and Therapeutic Antibody for New Outbreak of Pathogen ?Fu Gao, Vice President, Beijing Institutes of Life Science, Chinese Academy of Sciences; ?Director, CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology; Professor, ?University of Science and Technology of China |
| 09:45-12:30 | ?Session 3: The Scientific Frontier of Biological Discovery |
| Part I | ?Co-chairs: ?Ying Yang, Founder & CEO, LBD Life Sciences Ltd; Asia Council Chair, Society for Laboratory Automation and Screening (SLAS)? ?Bill Jiang, Director, Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University |
| 09:45-10:15 | ?Virus and Anti-Virus Drug Discovery ?Zihe Rao, Biophysicist & Structural Biologist; Professor & Former President, Nankai University; Academician, Chinese Academy of Sciences; President, Biophysical Society of China; President, ?International Union of Pure and Applied Biophysics (IUPAB) |
| 10:15-10:45 | ?Break in Exhibit Hall |
| Part II | ?Co-Chairs: ?Guang Yang, Vice Director, Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University ?Mingqiang Zhang, Vice President, R&D for China Amgen |
| 10:45-11:15 | ?Systems Approach to Translational Medicine ?Genhong Cheng, Director, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences; Professor, Department of Microbiology, Immunology & Molecular Genetics, UCLA |
| 11:15-11:45 | Therapeutic Antibody Discovery and Lead Selection Yan Wu, Associate Director, Genentech |
| 11:45-12:30 | ?Feature ?Talk and Panel Discussion: Case Study-NIBS’s ? ?Technology Transfer and Commercialization of Scientific Findings ?Moderator: Chengbin Wu, CSO and President of R&D, Shanghai CP Guojian Pharmaceutical Co., Ltd. ?Speaker: Xiaodong Wang, Biochemist; Director & Investigator, National Institute of Biological Science, China; Member, National Academy of Sciences, USA ?Panelist: ?Mingqiang Zhang, Vice President of R&D for China Amgen ?Yajun Xu, President of Shangpharma Investment; Executive Vice President, Shanghai Chempartner ?Bill Jiang, Director, Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University |
| 12:30-14:00 | ?Lunch in Exhibit Hall |
| 12:30-14:00 | ?Posters |
| 13:15-14:00 | ?Exhibitor Tutorial 3: ?Location: Nanjing Room, Level 5 ?Sponsored by ?? ?Exhibitor Tutorial 4: ?Location：Suzhou Room, Level 5 |
| 14:00-17:30 | ?Session 4: ADC - From Technology, Process, Discovery to Development (To be confirmed) |
| Part I | ?Co-chairs: ?Xueming Qian, Chairman & CEO, Mabspace Biosciences CO., LTD ?Yajun Xu, President of Shangpharma Investment; Executive Vice President, Shanghai Chempartner? |
| 14:00-14:30 | ?Antibody-Drug Conjugates for Cancer Therapy: Strategies and Perspectives ?Weikang Tao, CSO, Hengrui Pharmaceutical R&D |
| 14:30-15:00 | ?Site Specific Conjugation: Improvement of ADC Homogeneity and Druggability Properties ?Bruce Nianhe Han, CSO, NewBio Therapeutics? |
| 15:00-15:30 | ?R&D of Next-generation ADCs Based on LDC Technology ?Gang Qin, CEO, GeneQuantum Healthcare (Suzhou) Co., Ltd. |
| 15:30-16:00 | ?Biological Characterization of Antibody Drug Conjugates ?Mary Hu, CEO, Shanghai Miracogen Inc |
| 16:00-16:30 | ?Break in Exhibit Hall |
| Part II | ?Co-chairs: ?Zhenping Zhu, Executive Vice President, Global Biopharmaceuticals, Kadmon Corporation (New York); President, Kadmon China ?Chengbin Wu, CSO and President of R&D, Shanghai CP Guojian Pharmaceutical Co., Ltd. |
| 16:30-17:00 | ?A New Generation of Antibody-drug Conjugates for the Targeted Treatment of Cancer ?Robert Yongxin Zhao, CEO & Chairman, Hangzhou DAC Biotech Co., Ltd.? |
| 17:00-17:30 | ?Developing a Novel ADC for Global Market via Innovative Three-party Collaboration ?Chris Chen, Head of Biologics, Wuxi Apptec |
| 17:30-17:45 | ?Closing Remark (awarding) |
?
查看更多
會議嘉賓
（最終出席嘉賓以會議現(xiàn)場為準(zhǔn)）
|
? ?Karl Barry Sharpless, Ph.D |
? ?Fu Gao, PhD, MCAS |
|
? ?Zihe Rao, PhD, MCAS |
? ?Xiaodong Wang, PhD, MNAS |
?
查看更多
溫馨提示
酒店與住宿:
為防止極端情況下活動延期或取消，建議“異地客戶”與活動家客服確認(rèn)參會信息后，再安排出行與住宿。
退款規(guī)則:
活動各項資源需提前采購，購票后不支持退款，可以換人參加。
您可能還會關(guān)注
-
IWF上海國際健身展-全民健身節(jié)
2026-03-13 上海
-
2025全球智慧教育大會
2025-08-18 北京
-
2025年中國通用咨詢投資公司 產(chǎn)教融合創(chuàng)新發(fā)展大會
2025-08-06 天津
-
2025年下半年云南省高校教師資格認(rèn)定課程考試研修班
2025-10-01 昆明
贊助
